Large-scale sequencing analysis of the full-length cDNA library of human hepatocellular carcinoma

Journal of Biomedical Science

Volumn 10, Issue 6, 2003, Pages 636-643

  Tsai, Chia Chu ^a   Chung, Yi Da ^a   Lee, Hong Jen ^a   Chang, Wen Hsin ^a   Suzuku, Yutaka ^b   Sugano, Sumio ^b   Lin, Jung Yaw ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Full length cDNA library; Hepatocellular carcinoma; Hepatoma; Sequencing analysis

Indexed keywords

COMPLEMENTARY DNA;

AGED; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; DNA DETERMINATION; DNA LIBRARY; DNA REPAIR; DNA SEQUENCE; DNA STRUCTURE; GENE CONSTRUCT; GENE DELETION; GENE FUNCTION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; SCALE UP; SEQUENCE ANALYSIS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE LIBRARY; GENETICS; LIVER TUMOR; METABOLISM; CASE REPORT; CONTROLLED STUDY; DELETION MUTANT; GENE CLUSTER; GENE SEQUENCE; GENETIC ANALYSIS;

AGED; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION PROFILING; GENE LIBRARY; HUMANS; LIVER NEOPLASMS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEQUENCE ANALYSIS, DNA;

EID: 0242299675     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000073529     Document Type: Article

References (42)

1. Aberle H, Schwartz H, Kemler R. Cadherin-catenin complex: Protein interactions and their implications for cadherin function. J Cell Biochem 61:514-523;1996.
2. Austin H, Delzell E, Grufferman S, Levine R, Morrison AS, Stolley PD, Cole P. A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res 46:962-966; 1986.
3. Aviv H, Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA 69:1408-1412;1972.
4. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan. Lancet ii:1129-1133;1981.
5. Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 10:185-200;2000.
6. Chen YJ, Yeh SH, Chen JT, Wu CC, Hsu MT, Tsai SF, Chen PJ, Lin CH. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 119:431-440;2000.
7. Chen YJ, Chen PJ, Lee MC, Yeh SH, Hsu MT, Lin CH. Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization. Genes Chromosomes Cancer 35:138-143;2002.
8. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532-534;1993.
9. Chung EJ, Sung YK, Farooq M, Kim Y, Im S, Tak WY, Hwang YJ, Kim YI, Han HS, Kim JC, Kim MK. Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol Cells 14:382-387;2002.
10. Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene 18:4726-4733;1999.
11. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75:347-354;1998.
12. Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA 98:14601-14606;2001.
13. El-Serag HB. Hepatocellular carcinoma: An ep-idemiologic view. J Clin Gastroenterol 35:S72-S78;2002.
14. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S74-S83;2002.
15. Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J, Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 21:2593-2604; 2002.
16. Gumbiner BM. Signal transduction of beta-catenin. Curr Opin Cell Biol 7:634-640;1995.
17. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36:1206-1213; 2002.
18. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Hashimoto K, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S, Hamamoto Y. Differential gene expression in distinct virologic types of hepatocellular carcinoma: Association with liver cirrhosis. Oncogene 22:3007-3014; 2003.
19. Kim SO, Park JG, Lee YI. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: Implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Cancer Res 56:3831-3836;1996.
20. Lin YW, Sheu JC, Huang GT, Lee HS, Chen CH, Wang JT, Lee PH, Lu FJ. Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridisation in Taiwan. Eur J Cancer 35:652-658;1999.
21. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 18:59-65;1997.
22. Mercenier A, Chassy BM. Strategies for the development of bacterial transformation systems. Biochimie 70:503-517;1988.
23. Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51:5520-5525;1991.
24. Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K, Yamaoka Y, Ikenaga M, Imura H, Ishizaki K. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer 51:862-868;1992.
25. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M, et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54:3107-3110;1994.
26. Nishioka M, Kohno T, Tani M, Yanaihara N, Tomizawa Y, Otsuka A, Sasaki S, Kobayashi K, Niki T, Maeshima A, Sekido Y, Minna JD, Sone S, Yokota J. MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer. Proc Natl Acad Sci USA 99:12269-12274;2002.
27. Nishikawa T, Ota T, Kawai Y, Ishii S, Saito K, Yamamoto JI, Wakamatsu A, Ozawa M, Suzuki Y, Sugano S, Isocal T. Comparison of sequences of cDNA clones obtained from oligo-capping cDNA libraries with those from unigene. DNA Res 8:255-262;2001.
28. Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 62:163-182;1984.
29. Peng SY, Lai PL, Hsu HC. Amplification of the c-myc gene in human hepatocellular carcinoma: Biologic significance. J Formos Med Assoc 92:866-870;1993.
30. Sun CA, Wu DM, Lin CC, Lu SN, You SL, Wang LY, Wu MH, Chen CJ. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: A prospective study of 12,008 men in Taiwan. Am J Epidemiol 157:674-682; 2003.
31. Suzuki Y, Sugano S. Construction of a full-length enriched and a 5′-end enriched cDNA library using the oligo-capping method. Methods Mol Biol 221:73-91;2003.
32. Suzuki Y, Sugano S. Construction of full-length-enriched cDNA libraries. The oligo-capping method. Methods Mol Biol 175:143-153; 2001.
33. Terris B, Pineau P, Bregeaud L, Valla D, Bel-ghiti J, Tiollais P, Degott C, Dejean A. Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas. Oncogene 18:6583-6588;1999.
34. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol 44:92-95;1994.
35. Wang HP, Rogler CE. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet 48:72-78;1988.
36. Wang LY, You SL, Lu SN, Ho HC, Wu MH, Sun CA, Yang HI, Chien-Jen C. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: A cohort of 2,416 HBsAg-seropositive and 9,421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 14:241-250;2003.
37. Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, Sheng Z, Lau JW, Johnson PJ. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: Relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 154:37-43;1999.
38. Yakicier MC, Legoix P, Vaury C, Gressin L, Tubacher E, Capron F, Bayer J, Degott C, Balabaud C, Zucman-Rossi J. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma. Oncogene 20:5232-5238;2001.
39. Yang Y, Cun S, Xie X, Lin J, Wei J, Yang W, Mou C, Yu C, Ye L, Lu Y, Fu Z, Xu A. EST analysis of gene expression in the tentacle of Cyanea capillata. FEBS Lett 538:183-191; 2003.
40. Ye SQ, Usher DC, Zhang LQ. Gene expression profiling of human diseases by serial analysis of gene expression. J Biomed Sci 9:384-394; 2002.
41. Yeh CN, Lee WC, Jeng LB, Chen MF. Hepatic resection for hepatocellular carcinoma in Taiwan. Eur J Surg Oncol 28:652-656;2002.
42. Zhang WD, Hirohashi S, Tsuda H, Shimosato Y, Yokota J, Terada M, Sugimura T. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 81:108-111;1990.